Stocks
Aerie Pharmaceuticals (AERI) EBITDA US GAAP (year values) |
|||||||||
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -143.1 | -227.6 | -166.3 | -117.2 | -6.77 | -1.27 | ||
| Changes by years, y/y, % | +50% | +59% | -27% | -30% | -94% | -41.1% | |||
Aerie Pharmaceuticals. EBITDA US GAAP, bln rub
Aerie Pharmaceuticals. EBITDA US GAAP, changes, %
Aerie Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Aerie Pharmaceuticals (AERI) EBITDA US GAAP (quarter values) |
||||||||
| FY2021Q3 | FY2021Q4 | FY2022Q1 | FY2022Q2 | FY2022Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -22.7 | 65.1 | -30.0 | -14.7 | -21.7 | -1.27 | |
| Changes by years, y/y, % | -7% | -360% | +15% | -34% | -4% | |||
| Changes by quarters, q/q, % | +1% | -387% | -146% | -51% | +48% | |||
